Yatırımcı.AI

BISTTRY15:32Live

Orzaks İlaç ve Kimya Sanayi Ticaret A.Ş.

ORZAX Balance Sheet and Financial StatementsOrzaks İlaç ve Kimya Sanayi Ticaret A.Ş.

Main MarketChemicals, Petroleum, Rubber and Plastics
56.70−0.30 (−0.53%)
Volume
TRY 39.2M
Day range
52.65 – 57.45
Previous close
57.00
Market cap
TRY 19.2B

Last updated: Source: Borsa Istanbul, 15-minute delayed

The latest reported financial period for ORZAX is 2026/6. The table lists the last 3 periods from newest to oldest.

Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Orzaks İlaç ve Kimya Sanayi Ticaret A.Ş. (ORZAX), derived from KAP financial reports. Amounts are in TRY.

Financials

PeriodSales (Quarterly, TRY)EBITDA (Quarterly, TRY)Net profit (Quarterly, TRY)
2026/64.5B1.4B306.4M
2025/12——924.9M
2025/6———

Frequently Asked Questions

In the latest period (2026/6) ORZAX reported a net profit of TRY 306.4M, sales of TRY 4.5B and EBITDA of TRY 1.4B.

Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.

Net Profit

Sales

Quarterly Sales

Equity

EBITDA

Quarterly EBITDA

Total Assets

Total Liabilities